JAMA Internal Medicine masthead Online First JULY 17, 2023

VIEWPOINT

Mark D. Sullivan, MD, PhD; Jeffrey A. Linder, MD, MPH; Jason N. Doctor, PhD

Editor's Note: Opioid Dosing by Primary Care Professionals—A Call for Humility; Mitchell H. Katz, MD; Deborah Grady, MD

ORIGINAL INVESTIGATION

Ana Maria Copaescu, MD; Sara Vogrin, MBiostat; Fiona James, BBiomedSci; et al.

INVITED COMMENTARY

Raman Khanna, MD, MAS; Andrew Auerbach, MD, MPH

EDITOR'S NOTE

Mitchell H. Katz, MD; Deborah Grady, MD

Eric Ward, MD; Cary Gross, MD

REVIEW

Ngan Thi Thuy Phi, MSc; Theodora Oikonomidi, MSc, PhD; Philippe Ravaud, MD, MSc, HDR, PhD; et al.

Earn CME credit

RESEARCH LETTER

Ashwin Nayak, MD, MS; Matthew S. Alkaitis, MD, PhD; Kristen Nayak, MD; et al.

Editor's Note: Evolving Methods to Assess Chatbot Performance in Health Sciences Research; Eric Ward, MD; Cary Gross, MD

Eric Strong, MD; Alicia DiGiammarino, MS; Yingjie Weng, MHS; et al.

Editor's Note: Evolving Methods to Assess Chatbot Performance in Health Sciences Research ; Eric Ward, MD; Cary Gross, MD

CHALLENGES IN CLINICAL ELECTROCARDIOGRAPHY

Zhongzheng Zhou, MD; Yi Long, MD; Yong Li, MD

Earn CME credit

BREAKING: DONANEMAB FOR ALZHEIMER DISEASE

John R. Sims, MD; Jennifer A. Zimmer, MD; Cynthia D. Evans, PhD; et al.

Editorial: Donanemab for Alzheimer Disease—Who Benefits and Who Is Harmed? ; Jennifer J. Manly, PhD; Kacie D. Deters, PhD

Editorial: Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease; Gil D. Rabinovici, MD; Renaud La Joie, PhD

Editorial: Novel Alzheimer Disease Treatments and Reconsideration of US Pharmaceutical Reimbursement Policy; Meredith B. Rosenthal, PhD

Editorial: Ushering in a New Era of Alzheimer Disease Therapy; Eric W. Widera, MD; Sharon A. Brangman, MD; Nathaniel A. Chin, MD

COMMENT & RESPONSE

Less Is More

Vasu Sareen, MD; Daniel Ho, MD

Nirvik Pal, MBBS, MD; Mark Nelson, MD; John Butterworth, MD

Less Is More

Weiwei Beckerleg, MD, MPH; Daniel I. McIsaac, MD, MPH